Group 1 - The company is undergoing a board of directors re-election process, with the fifth board consisting of 9 members: 5 non-independent directors, 3 independent directors, and 1 employee representative director [1][2] - The candidates for the fifth board have been nominated and include both non-independent and independent directors, with qualifications verified by the board's nomination committee and approved by the Shanghai Stock Exchange [2][3] - The new board will serve a term of three years starting from the approval date by the shareholders' meeting [2] Group 2 - The company has announced changes to its registered capital, increasing it from 151,202,081 yuan to 151,203,652 yuan due to the conversion of convertible bonds [10] - The company is expanding its business scope to include a wider range of manufacturing and sales activities, particularly in medical packaging materials and various types of glass and plastic products [11][12] - The company will no longer have a supervisory board, with its functions being transferred to the audit committee of the board of directors, in compliance with the new Company Law [13][14] Group 3 - The company is revising its articles of association to reflect the cancellation of the supervisory board, the changes in registered capital, and the expansion of its business scope [14][15] - The company is also updating its governance systems to align with the latest legal requirements, including the revision of rules related to shareholder meetings, board meetings, and independent directors [17]
重庆正川医药包装材料股份有限公司 关于董事会换届选举的公告